Last update:

Overweight & Obesity news

Overweight & Obesity

High levels of adrenomedullin found to promote obesity-associated insulin resistance

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according to research conducted by the Max Planck Institute for Heart and Lung Research in Germany.

Surgery

Study confirms that bariatric surgery is safe and reduces the need for diabetes medication

Bariatric surgery is safe and induces substantial weight loss that reduces the need for diabetes medications, a Monash University and University of Sydney-led Australian study has found.

Overweight & Obesity

Prescriptions for obesity management drugs increasing

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends, according to a study published online Jan. 29 in JAMA Network Open.

Overweight & Obesity

3D imaging and AI enhance body fat and muscle distribution analysis

A recent study introduces an innovative method for analyzing body composition using advanced 3D imaging and deep learning techniques. This approach aims to provide more accurate assessments of body fat and muscle distribution, ...

Health

Calorie labels on menus could make eating disorders worse

Calorie labels on restaurant menus are negatively impacting people with eating disorders, according to a new study published in BMJ Public Health. The review, which is the first of its kind, is led by researchers at King's ...

Overweight & Obesity

A vaccine to prevent weight gain? It's on the horizon

This time of year, millions of people turn to diets, exercise and medication to help them get their weight in check. New University of Colorado Boulder research suggests another surprising tool could help them achieve their ...

Cardiology

How do GLP-1s boost weight loss and heart health?

Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds.

Medications

FDA approves first generic liraglutide once-daily injection

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults ...